|Daniel Touchette, PharmD, MA|
|Office||287B PHARM m/c 886|
|US Mail||833 S. Wood St., RM 164 MC886 |
Chicago, IL 60612
|Dr. Touchette is an Associate Professor of Pharmacy at the University of Illinois at Chicago College of Pharmacy and a Core Faculty Member of the UIC Center for Phamacoeconomic Research. Dr. Touchette’s research program has focused on health policy analysis, including health technology assessment, assessing pharmacist and physician practice patterns, improving models for care, assessing the impact of adherence on clinical and economic outcomes, and the comparative effectiveness of diabetes medications. To date, Dr. Touchette has over 30 publications. Among the numerous grants and contracts, Dr. Touchette is currently leading three large prospective, comparative effectiveness studies involving patient adherence to medications: one, an evaluation of a medication therapy management (MTM) intervention funded through |
the Agency for Healthcare Research and Quality; the second, an evaluation of a remote electronic
medication management assistance device in patients with traumatic brain injury or post-traumatic stress disorder taking multiple medications funded through the Department of Defense; and the last an evaluation
of a community pharmacist intervention designed to reduce therapeutic gaps in care for State employees
and retirees funded by Medco Health Solutions. Dr. Touchette also serves as the Network Director for the American College of Clinical Pharmacy’s Practice-based Research Network.
|2000||MA (Economics), Wayne State University Detroit, MI|
|1999||Fellowship in Pharmacoeconomic and Outcomes Research, Wayne State University |
|1997||PharmD, Wayne State University Detroit, MI|
|1991||BSc (Pharm), University of Manitoba Winnipeg, Manitoba|
|Current UIC Appointments|
|2011 to Present||Associate Professor, Department of Pharmacy Practice|
- Hunt J, Siemienczuk J, Touchette DR, Payne N. Impact of Educational Mailing on the Blood Pressure of a Population of Primary Care Patients with Mild Hypertension. J Gen Intern Med. 2004 Sep;19(9):925-30.
- Touchette DR, Burns AL, Bough MA, Blackburn JC. Survey of medication therapy management programs under Medicare Part D. J Am Pharm Assoc 2006; 46: 683-691.
- Touchette DR, Masica A. Evidence needed for policy decisions: adherence interventions and Medicare Part D. Arch Intern Med. 2007;167(17):1905. (Letter)
- Touchette DR, Shapiro NL. Medication compliance, adherence and persistence: current status of behavioral and educational interventions to improve outcomes. J Man Care Pharm 2008; 16(6d): S2-S10.
- Masica A, Touchette DR, Dolor R, Craft J, Kliethermes MA, Rodgers P, Lux L, Smith SR, Schumock GT. Evaluation of a medication therapy management program on patient safety in Medicare beneficiaries at high risk of adverse drug events: study methods. Advances in Patient Safety. Volume 4 / Technology and Medication Safety (AHRQ 08-0034-4) http://www.ahrq.gov/qual/advances2/#v1
- Kim SL, Touchette DR, Stubbings J, Schullo-Feulner AM, Pater KS. Pilot assessment of patient satisfaction and clinical impact of Medicare Part D in diabetic geriatric patients. Pharmacy Practice 2008; 6(3): 128-135.
- Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, Touchette DR. Impact of pharmacy practitioners on management of hypertension: A randomized controlled trial. J Gen Intern Med 2008; 23(12):1966-1972.
- Pellegrino AN, Martin M, Tilton J, Touchette DR. Medication therapy management definitions and outcomes. Drugs 2009; 69(4): 393-406.
- Lau DT, Briesacher BA, Touchette DR, Stubbings J, Ng J. Medicare part D and medication therapy management programs: Evidence on quality of prescription medication use. Drugs Aging 2011; 28(10): 797-807.
- Touchette DR, Rao S, Dhru P, Zhao W, Choi Y-K, Bhandari I, Stettin GD. Identification of and intervention to address therapeutic gaps in care in community pharmacies: The Illinois Project. Am J Manag Care 2012;18(10):e364-e371.
- Touchette DR, Masica AL, Dolor RJ, Schumock GT, Choi YK, Kim Y, Smith SR. The medication evaluation and drug use problem identification to improve safety in high risk Medicare beneficiaries (MEDIS-MB) study: Main results. J Am Pharm Assoc 2012; 52: 603-612.
- Gerber BS, Rapacki L, Castillo A, Tilton J, Touchette DR, Mihailescu D, Berbaum M, Sharp L. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes. BMC Public Health 2012;12(1):891.
- Kuo GM, Touchette DR, Marinac JS, for the American College of Clinical Pharmacy Practice-Based Research Network Collaborative. Drug errors and related interventions reported by United States clinical pharmacists: The American College of Clinical Pharmacy Practice-Based Research Network Medication Error Detection, Amelioration and Prevention study. Pharmacotherapy 2013; 33 (3): 253–265.